
Judit Filotas
16 July 2026
Antibody–Drug Conjugates (ADCs): CMC Development and Regulatory Strategies
6-hour
Introduction to ADCs and Their CMC Challenges, Manufacturing Considerations, Analytical and Quality Considerations, Regulatory Landscape for ADCs, CMC Development Strategies, Case Studies and Best Practices
Andrew Willis
JF
Issued to
Judit Filotas
Want to report a typo or a mistake?
Credential Verification
Issue date: July 16, 2026
ID: 4df10859-31ad-4b92-b0e9-87a01ecb7230
Type
Course
Level
Professional
Price
Paid
Earning Criteria
Participation
Attended the course held by Educo Life Sciences.
Watching
Or watched the recorded materials for the course held by Educo.